Mehrdad Ghorbanlou

Dr. Mehrdad Ghorbanlou


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2022 in Forensic Imaging
Verified
Journal Article
Closed access
MGMehrdad Ghorbanlou
Mehrdad Ghorbanlou
FMFatemeh Moradi
Fatemeh Moradi
HAHamid Reza Asgari
Hamid Reza Asgari

31 March 2022 in Anatomy & Cell Biology
Verified
Journal Article
Open access
PDF file
MGMehrdad Ghorbanlou
Mehrdad Ghorbanlou
FMFatemeh Moradi
Fatemeh Moradi
MMmehdi mehdizadeh
mehdi mehdizadeh
Mehrdad Ghorbanlou, Fatemeh Moradi, Mehdi Mehdizadeh. Anat Cell Biol 2022;55:63-71. https://doi.org/10.5115/acb.21.137

11 December 2023 in Anatomy & Cell Biology
Verified
Journal Article
Open access
PDF file
MGMehrdad Ghorbanlou
Mehrdad Ghorbanlou
FMFatemeh Moradi
Fatemeh Moradi
MKMohammad Hassan Kazemi-galougahi
Mohammad Hassan Kazemi-galougahi
MAMaasoume Abdollahi
Maasoume Abdollahi
Mehrdad Ghorbanlou, Fatemeh Moradi, Mohammad Hassan Kazemi-Galougahi, Maasoume Abdollahi. Anat Cell Biol 2024;57:45-60. https://doi.org/10.5115/acb.23.219

22 December 2023 in Journal of Chemotherapy
Verified
Journal Article
Closed access
MGMehrdad Ghorbanlou
Mehrdad Ghorbanlou
FMFatemeh Moradi
Fatemeh Moradi
RSRonak Shabani
Ronak Shabani
MMmehdi mehdizadeh
mehdi mehdizadeh
Sonic hedgehog (SHH) medulloblastoma etiology is associated with the SHH molecular pathway activation at different levels. We investigated the effect of arsenic trioxide as a downstream-level inhibitor of the SHH signaling pathway on morphology, cytotoxicity, migration, and SHH-related and apoptotic gene expression of DAOY cells. Cells were treated at various arsenic trioxide (ATO)concentrations (1, 2, 3, 5, and 10 mu M) for different times (24 and 48 hr). Following treatments, the morphology of the cells was investigated at x20 and x40 magnification by an inverted microscope. Then, cytotoxicity was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and trypan blue assays. Cell migration was analyzed through the wound-healing assay. Furthermore, the expression of SHH-related (GLI1, GLI2, SMO, and MYCN) and apoptotic genes (BAX, BCL2, and TP53) was assessed by real-time quantitative polymerase chain reaction (qPCR). Finally, GLI1, SMO, and MYCN markers were analyzed through immunocytochemistry. Data were analyzed by SPSS (version 16) and P <= 0.05 was considered significant. Morphological changes were seen at 3 and 2 mu M in 24 and 48 hr of treatment, respectively. The MTT assay showed a dose-dependent cytotoxicity indicating an IC50 value of 3.39 +/- 0.35 and 2.05 +/- 0.64 mu M in 24 and 48hr treatment, respectively. In addition, the trypan blue assay showed higher IC50 values of 4.29 +/- 0.25 and 3.92 +/- 0.22 mu M in 24 and 48 hr treatment, respectively. The wound-healing assay indicated a dose-dependent reduction of cell migration speed showing a 50% reduction at 2.89 +/- 0.26 mu M. Significant downregulation of GLI1 and GLI2, as well as the upregulation of BAX, BAX/BCL2 ratio, and TP53 were evident. Significant increases in GLI1 and MYCN markers were also evident in immunocytochemistry. ATO, as a downstream effective inhibitor of the SHH pathway, substantially leads to cell death, cell migration inhibition, apoptosis upregulation, and downregulation of SHH target genes in DAOY medulloblastoma. Since ATO is a toxic chemotherapeutic agent, it must be used at low concentrations (2 mu M) in order not to damage healthy cells.

1 May 2025 in Basic and Clinical Neuroscience Journal
Verified
Journal Article
Open access
PDF file
MBMasume Behruzi
Masume Behruzi
MGMehrdad Ghorbanlou
Mehrdad Ghorbanlou
RSRonak Shabani
Ronak Shabani
ARAoub Rustamzadeh
Aoub Rustamzadeh
EGEnam Alhagh Charkhat Gorgich
Enam Alhagh Charkhat Gorgich
FMFatemeh Moradi
Fatemeh Moradi
Introduction: Targeting smoothened (SMO) has been a remarkable strategy for treating sonic hedgehog (Shh)-dependent cancers, especially medulloblastoma. GDC-0449, also known as vismodegib, is a potent SMO inhibitor with mild toxicity and high affinity. Thus, this study aimed to investigate the anti-medulloblastoma efficacy of vismodegib in the DAOY medulloblastoma cell line. Methods: Human ...

19 December 2023 in Canadian Society of Forensic Science Journal
Verified
Journal Article
Closed access
MGMehrdad Ghorbanlou
Mehrdad Ghorbanlou
FMFatemeh Moradi
Fatemeh Moradi
HAHamidreza Asgari
Hamidreza Asgari